Research programme: DNA minor groove binding agents - Spirogen
Alternative Names: DRG 16; Project P080; SG 2057Latest Information Update: 10 Aug 2021
At a glance
- Originator Spirogen
- Class Benzodiazepines; Pyrroles
- Mechanism of Action DNA cross linking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bacterial infections; Cancer
Most Recent Events
- 15 Oct 2013 Spirogen has been acquired by MedImmune
- 15 Oct 2013 No development reported for Cancer in United Kingdom (unspecified route)
- 15 Oct 2013 No development reported for Bacterial infections in United Kingdom (unspecified route)